Are endometriosis patients a high-risk population?
To date, there is no evidence that women with endometriosis are at increased risk of COVID-19.7 However, women with endometriosis within the chest cavity (in the lungs or on the diaphragm), referred to as ‘thoracic endometriosis’, may be more at risk. Similarly, there is no evidence that COVID-19 will hasten the progression/development of endometriosis. Nonetheless, the pandemic will likely contribute to a reduction in quality of life secondary to a delay in diagnosis and/or the treatment of endometriosis owing to the temporary closure of outpatient services, (including complementary therapies), postponement of planned surgical or fertility treatments, and an eventual increase in the waitlist for services once they resume. The extent of the impact will depend on the duration of service postponement and regional resource variations (e.g. access to operating theatre time when surgeries resume).